3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Exostoses, Multiple Hereditary
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Breast Cancer Lymphedema
1
BTC
1
Interventions
pembrolizumab
18
Specimen Handling
17
Magnetic Resonance Spectroscopy
12
Biopsy
12
Paclitaxel
9
Carboplatin
8
Radiosurgery
7
Nivolumab
7
trastuzumab deruxtecan
6
Pemetrexed
6
Leucovorin
6
Irinotecan
6
Fulvestrant
6
Fluorouracil
6
Bevacizumab
6
palbociclib
5
Oxaliplatin
5
Letrozole
5
Gemcitabine
5
Cetuximab
5
Taxes
4
Cisplatin
4
Capecitabine
4
olaparib
3
enzalutamide
3
durvalumab
3
Ipilimumab
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.